Outcomes of autologous bone marrow mononuclear cell administration combined with educational intervention in the treatment of autism spectrum disorder: a randomized, open-label, controlled phase II clinical trial. - Nguyen LT; Nguyen PM; Nguyen HP; Bui HT; Dao LTM; Van Pham M; Hoang CK; Nguyen PT; Nguyen TTP; Nguyen ATP; Hoang VT; Bui HTP; et al. (Stem cell research & therapy, 2025)